Originally published In Press as doi:10.1074/jbc.M110803200 on March 18, 2002
J. Biol. Chem., Vol. 277, Issue 24, 21630-21638, June 14, 2002
Identification of Calmodulin Isoform-specific Binding Peptides
from a Phage-displayed Random 22-mer Peptide Library*
Ji Young
Choi
§,
Sang Hyoung
Lee
§,
Chan Young
Park
§¶,
Won Do
Heo
¶,
Jong Cheol
Kim
¶,
Min
Chul
Kim
¶,
Woo Sik
Chung
¶,
Byeong Cheol
Moon¶,
Yong Hwa
Cheong
¶,
Cha Young
Kim
¶,
Jae Hyuk
Yoo
,
Ja Choon
Koo
¶,
Hyun Mi
Ok¶,
Seung-Wook
Chi
,
Seong-Eon
Ryu
,
Sang Yeol
Lee
¶,
Chae Oh
Lim
¶, and
Moo Je
Cho
¶**
From the ¶ Division of Applied Life Science (BK21 Program),
Plant Molecular Biology and Biotechnology Research
Center, Gyeongsang National University, Chinju 660-701 and the
Center for Cellular Switch Protein Structure, Korea Research
Institute of Bioscience and Biotechnology, 52 Euh-eun-dong, Yusong,
Daejon 305-333, Korea
Received for publication, November 12, 2001, and in revised form, March 15, 2002
 |
ABSTRACT |
Plants express numerous calmodulin (CaM)
isoforms that exhibit differential activation or inhibition of
CaM-dependent enzymes in vitro; however, their
specificities toward target enzyme/protein binding are uncertain. A
random peptide library displaying a 22-mer peptide on a bacteriophage
surface was constructed to screen peptides that specifically bind to
plant CaM isoforms (soybean calmodulin (ScaM)-1 and SCaM-4 were used in
this study) in a Ca2+-dependent manner. The deduced amino
acid sequence analyses of the respective 80 phage
clones that were independently isolated via affinity panning
revealed that SCaM isoforms require distinct amino
acid sequences for optimal binding. SCaM-1-binding
peptides conform to a 1-5-10 ((FILVW)XXX(FILV) XXXX(FILVW))
motif (where X denotes any amino acid), whereas
SCaM-4-binding peptide sequences conform to a 1-8-14 ((FILVW)XXXXXX(FAILVW)XXXXX(FILVW)) motif. These motifs are classified based on the positions of conserved hydrophobic residues. To examine their binding properties further, two
representative peptides from each of the SCaM isoform-binding sequences
were synthesized and analyzed via gel mobility shift assays, Trp
fluorescent spectra analyses, and phosphodiesterase competitive
inhibition experiments. The results of these studies suggest that SCaM
isoforms possess different binding sequences for optimal target
interaction, which therefore may provide a molecular basis for CaM
isoform-specific function in plants. Furthermore, the isolated peptide
sequences may serve not only as useful CaM-binding sequence references
but also as potential reagents for studying CaM isoform-specific
function in vivo.
 |
INTRODUCTION |
CaM1 is a ubiquitous
intracellular Ca2+ receptor involved in transducing a
variety of extracellular signals (1-3). In contrast to mammals, many
plant species belong to a CaM multigene family that encodes various CaM
isoforms (4-5). Over 30 genes encoding CaM isoforms are found in the
complete nucleotide sequence of Arabidopsis
thaliana.2 CaMs function
by modulating or regulating the activities of their target proteins
(CaM-binding proteins). More than 30 CaM-binding proteins have been
identified, including enzymes such as kinases, phosphatases, and
nitric-oxide synthase, as well as receptors, ion channels, G-proteins,
and transcription factors (7-9). Plants seem to have evolved a unique
repertoire of CaM targets whose homologues in animals do not appear to
be modulated by CaMs. The shear number of CaM isoforms and the
diversity of CaM targets imply that these proteins in plants likely
modulate a broad spectrum of processes.
CaM is dumbbell-shaped with the N- and C-terminal globular domains
separated by a flexible central helix. Each lobe contains two
helix-loop-helix Ca2+-binding motifs referred to as
"EF-hands" that are interconnected by a small
-sheet between the
two Ca2+-binding loops (10). Ca2+ binding to
CaM induces conformational changes that expose hydrophobic amino acid
residues on the surface of both lobes. This creates two hydrophobic
pockets that are important for target peptide binding. CaM binds to a
large number of proteins through interactions with specific CaM-binding
domains. Therefore, one of the most intriguing questions
concerning the interaction of CaM with target proteins is: how does a
phylogenetically conserved protein like CaM specifically interact with
so many different target sites? The determination of the
three-dimensional structures of the CaM-peptide complexes greatly aided
in answering this question (11-15).
Many known Ca2+-dependent CaM-binding proteins
possess a region that is often characterized by an amphipathic helix
consisting of ~20 amino acid residues. This region contains two
hydrophobic/aromatic residues that are separated by 12 intervening
residues that anchor the peptide to the two lobes of CaM (2). However,
sequence analyses based upon this criteria do not always identify the
CaM-binding region of a protein, and therefore, the CaM-binding regions
of target proteins do not always fit these criteria. Furthermore, the
presence of a novel class of CaM-binding proteins that assume a
non-helical conformation in the CaM complex has been suggested (16).
The CaM-binding domains of these proteins are characterized by the
dominance of basic amino acids in contrast to the canonical motif in
which hydrophobic amino acids are dominant. An attempt was made to
examine the elements common to the many reported CaM-binding regions
from different proteins. From sequence comparisons of CaM-binding
peptides and CaM-binding domains within the CaM-regulated proteins,
three classes of CaM-binding motifs have emerged (17). They include a
modified variant of the IQ motif as a consensus for
Ca2+-independent binding and two related motifs for
Ca2+-dependent binding, termed 1-8-14 and
1-5-10 (based on the conserved hydrophobic residues within these
motifs). Based on these structures and sequence information, a
web-based data base is available for quickly searching for a potential
CaM-binding site in a given protein sequence (18).
In plant cells, multiple CaM genes code for numerous CaM isoforms in
wheat (19), potato (20), Arabidopsis (21), and soybean (22).
We have recently cloned five CaM isoforms from soybean (SCaM-1-5).
Although some of these isoforms (i.e. SCaM-1-3) are more
than 90% identical to mammalian CaM, two (SCaM-4 and SCaM-5) exhibit
only a 78% homology with SCaM-1 and are therefore the most divergent
isoforms reported thus far in the plant and animal kingdoms. SCaM-4 is
considered a bona fide CaM isoform based on the following
characteristics. At primary structure level, SCaM-4 has conserved four
putative EF-hands and a central linker region, hallmarking structural
features of CaM (22). In addition, most of amino acid exchanges occur
outside EF-hands, and the number of total amino acid residues are also
conserved (148 amino acid residues for SCaM-1 and mammalian CaM, and
149 amino acid residues for SCaM-4 (22)). When compared with the
preferred consensus amino acid residues of EF-hands derived from known
Ca2+-binding proteins (23), the residues in all four
Ca2+-binding loops of SCaM-4 conform to the consensus (Fig.
1), suggesting that SCaM-4 can bind four
Ca2+ molecules. All SCaM isoforms including SCaM-4 are
ubiquitously expressed in various plant tissues and show similar
subcellular localization patterns to the highly conserved SCaM-1 (22,
24). Intriguingly, the cellular level of SCaM-4 rapidly rises upon specific stimuli such as pathogen infection in the same cells constitutively expressing SCaM-1 (25). Furthermore, SCaM-4 has the
ability to modulate activity of many CaM-dependent enzymes. However, SCaM-4 has distinguished ability from SCaM-1 in the activation of CaM target enzymes, which can be categorized into three different types (22, 26-29) as follows: 1) enzymes activated equally by both
SCaM-1 and SCaM-4 (e.g. phosphodiesterase (PDE), plant
Ca2+-ATPase, plant glutamate decarboxylase, and
CaM-dependent protein kinase II); 2) enzymes activated only
by SCaM-1 (e.g. calcineurin, myosin light chain kinase, red
cell Ca2+-ATPase, and plant NAD kinase); and 3) enzymes
activated only by SCaM-4 (e.g. nitric-oxide synthase).
SCaM-1 and SCaM-4 also exhibit differences in their Ca2+
concentration requirements for target enzyme activation (28). Studies
defining CaM-binding sequences and analyzing their interactions with
CaM have shed light on the specificity of the interactions between CaM
and the particular target molecules.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1.
Comparison of amino acid sequences of four
EF-hands from SCaM-1, SCaM-4, and bovine brain CaM
(B-CaM). Consensus shows the most frequently
observed amino acid residue in each position of the
Ca2+-binding loop region of EF hand, which is derived from
the comparison of known Ca2+-binding proteins (23).
Underlined amino acid residues indicate higher than 70%
conservation. Ca2+-binding ligands are denoted by
asterisks, and residues conformed to the consensus are
indicated by boldface letters.
|
|
Here we have adapted an approach for defining the SCaM-1 and
SCaM-4-binding peptide sequences using a random peptide bacteriophage display library. Bacteriophage display and affinity selection of
phage-displayed peptide libraries, a technique based on screening a
library of foreign peptides displayed on the surface of M13 bacteriophage, has proven to be a very useful tool for characterizing a
number of protein-protein interactions. Due to the physical linkage of
the expressed peptide with its genetic sequence, libraries numbering
from 108 to 1010 peptides have been rapidly
screened for a wide variety of applications. This useful tool has been
used to map antibody epitopes and to discover peptide ligands for
membrane receptors and cytosolic proteins in recent years (30). In this
work, we have searched SCaM isoform (SCaM-1 and -4)-favored peptide
sequences from a phage display library, and we defined novel SCaM-1-
and SCaM-4-specific binding sequences. Furthermore, we have analyzed
the interactions between SCaM-1 and SCaM-4 and their respective binding
peptides using a variety of biochemical techniques including gel
overlay, gel mobility shift, fluorescence spectroscopy, and
phosphodiesterase competition assays. Our data show that SCaM isoforms
possess different sequences for optimal binding to specific targets.
This may provide a molecular basis for CaM isoform-specific function in plants.
 |
EXPERIMENTAL PROCEDURES |
Construction of a Random 22-mer Phage Library--
The phagemid
vector pCANTAB5E (Amersham Biosciences) was modified to
construct a vector for our library (Fig.
2A). Two oligonucleotides (5'-CCGGCCGGCGATATCAGCGGC-3' and
5'-GGCCGCGCCGCTGATATCGCCGGCCGGCT-3') were mixed, heated to 75 °C for
10 min, and allowed to hybridize by cooling slowly at room temperature
for 30 min. The hybrids were inserted at the NotI and
SfiI site of pCANTAB5E to introduce NotI and
EcoRV sites and a sequence coding for junction amino acid
residues. The resulting phage peptide library vector was named
pCANTAB5F. These vectors were digested with NotI and
EcoRV to clone double-stranded DNA coding for random
peptides. This process is shown in Fig. 2B.
Single-stranded DNA encoding 22-residue random peptides
(5'-(NNK)22GCGGCCGCAGGTGCGC-3') and one oligonucleotide (5'-GCGCACCTGCGGCCGC-3'), in which N is A, C, G, or T
(equimolar), and K is C or T (equimolar) were hybridized and converted
into double-stranded DNA using Klenow DNA polymerase. The DNA was cut by NotI to produce one blunt end and one NotI
site and then ligated into pCANTAN5F. The resulting DNA sequence and
amino acid sequence of the N-terminal region of gpIII are shown in Fig.
2C. Twenty electroporations, each using 0.5 µg of the DNA
constructed as above and 100 µl of electrocompetent Escherichia
coli TG1 cells, yielded 4.2 × 108 transformants
producing infectious phages. The helper phage M13K07 was used to
produce a phage library from the bacteria harboring library
phagemids.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
Construction of the random peptide
library. Recognition sequences and restriction sites of enzymes
are indicated by boxes and edged lines,
respectively. The letter N stands for an
equal mixture of A, G, C, and T, and K stands for an equal
mixture of Cys and Thr. A, procedure is described for
construction of the peptide library vector pCANTAB5F. The amino acid
sequence at the N terminus of gpIII and the corresponding DNA sequences
are shown. Boldface letters correspond to the substituted or
inserted residues. B, procedure is depicted for construction
of double-stranded DNA coding for random peptides. C, amino
acid sequence is listed for the random peptide, indicated as
X22. The corresponding DNA sequence is also
shown.
|
|
Isolation of SCaM Isoform Binding Phages by Biopanning--
The
library was screened either with SCaM-1 or SCaM-4 isoforms (22) coated
on 35 × 10-mm plastic Petri dishes. These Petri dishes were
coated with SCaM isoforms by incubating them with 1 ml of the SCaM
protein (100 µg/ml in TBS) for 1 h at 37 °C. The residual
binding capacity of the dish was blocked with 0.1% BSA. About 2.3 × 1011 colony-forming units of the phage library in TBS
(150 mM NaCl in 50 mM Tris-HCl, pH 7.5), 0.1%
Tween 20 were preincubated with 0.1% BSA for 1 h at room
temperature to remove BSA-binding phages and were bound to the
SCaM-coated dishes by incubating them overnight at 4 °C. The plates
were washed ten times for 5 min with 1 ml of TBS, 0.1% Tween 20 to
remove unbound phages. Phages bound to SCaM-1 or SCaM-4 were eluted in
TBS, 0.1% Tween 20 with 2 mM EGTA. The eluted phages were
amplified by infecting logarithmic phase E. coli TG1. The
helper phage M13K07 was introduced into infected cells to produce
phages. The resulting phages were subjected to an additional two rounds
of biopanning. SCaM-1 or SCaM-4-binding phages obtained by three rounds
of the selection process were plated with E. coli TG1 to
raise colonies. Each clone was grown in 1 ml of 2× YT medium
supplemented with 100 µg/ml ampicillin at 37 °C, shaking to a late
log phase. After adding the Helper phage M13K07, the culture was
further incubated overnight, and a clear phage supernatant was
collected following a 5-min centrifugation. Each of the phages was
transferred into a 96-well microtitration plate coated with the SCaM-1
and -4 isoforms as in the above biopanning method. These were tested
for the binding affinities of the selected phages to SCaM-1 and -4 by
enzyme-linked immunosorbent assay using an HRP-conjugated anti-M13
antibody (Amersham Biosciences). The reaction of HRP with
2',2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) was quantified
by measuring the absorbance at 410 nm in a microplate spectrophotometer.
Expression of Recombinant GST Peptide Fusion Proteins in E. coli--
Inserts of selected clones were amplified by PCR
using modified primers both upstream and downstream of the gene
III sequence (5'- TTAGCCATGGCTTTCTATGCGGCCCAG-3' and
5'-AGCGGACCCGGGTACGGCACCGGCGCA-3'), where the
underlined nucleotides represent the SmaI and
NcoI recognition sequence. PCR was performed using a
temperature program consisting of 25 cycles of 1 min at 95 °C, 1 min
at 55 °C, and 1 min at 72 °C, followed by one cycle of 5 min at
72 °C. After amplification, the PCR products were digested with
SmaI and NcoI and cloned in SmaI- and
NcoI-cleaved GST fusion vector, pGEX-KG (31). The ligated
DNAs were used to transform E. coli BL21 cells. DNA was prepared as above from the cultures of individual colonies, and recombinants were identified by digestion with SmaI and
NcoI and confirmed by DNA sequence analysis. Recombinant DNA
techniques including transformations, plasmid preparations, gel
electrophoresis, ligations, and enzyme digestions were all carried out
according to Sambrook et al. (32). Purification of DNA from
agarose gels was performed with a QIAEX II purification kit (Qiagen).
For the preparation of GST fusion proteins, transformants were grown in
liquid cultures with ampicillin selection to an optical density of 0.5 at 600 nm. 1 mM
isopropyl-1-thio-
-D-galactopyranoside was then added,
and the cultures were further incubated for 18 h at 37 °C.
Cells were collected by centrifugation and stored at
20 °C or less
until used. Frozen cells were thawed on ice and resuspended in buffer M
(20 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, 5 mM 2-mercaptoethanol, 2 mM phenylmethylsulfonyl
urea, 0.1 mM p-aminobenzamidine), and the cell
suspensions were sonicated for 1 min at a 20% pulse. After clearing
the lysate by centrifugation at 15,000 rpm for 10 min at 4 °C, the
supernatant (designated as the crude CaM-PEP preparation) was used for
the binding assays.
CaM Gel Overlay Assay--
To prepare horseradish peroxidase
(HRP)-conjugated CaMs, we conjugated SCaMs with a maleimide-activated
HRP using the EZ-Link maleimide-activated HRP conjugation kit (Pierce)
according to the manufacturer's instructions. Before conjugation,
SCaMs were incubated in 50 mM Hepes, pH 7.0, 0.1 M dithiothreitol at 55 °C for 1.5 h to reduce
cysteine residues. The reduced SCaMs were washed and concentrated in
degassed phosphate-buffered saline buffer using Centricon C10s
(Amicon). After conjugation, the efficiency of SCaMs conjugation to HRP
was determined by SDS-PAGE. Conjugation efficiency was usually greater
than 90%. Unconjugated residual CaM was removed by gel filtration. CaM
gel overlays were performed as described previously (33). Ten µg of
GST fusion protein was separated on an 11% SDS-polyacrylamide gel.
DNA Sequencing--
DNA sequencing was carried out using
primers (5'-CCATGATTACGCCAAGCTTTGGAGCC-3' and
5'-GTAAATGAATTTTCTGTATGAAG-3') and an Applied Biosystems
automatic sequencer (PerkinElmer Life Sciences).
Peptide Synthesis--
Peptides (Pep A, APAHALFHWGVLGSLIRLVFLS,
and Pep B, CNRLLLRSLRYWGYVVLSALRL) were synthesized at the Peptide
Synthesis Facility (Peptron, DaeJun, South Korea) using an Applied
Biosystems model instrument. Peptides were desalted and purified by
reverse-phase high pressure liquid chromatography using a
C18 column, and their amino acid sequences were analyzed.
Gel Mobility Shift Assays--
The abilities of the synthetic
peptides (i.e. Pep A and B) to bind to the SCaM-1 and SCaM-4
isoforms were examined by the relative mobility shifts of the
CaM-peptide complexes using 4 M urea polyacrylamide gel
electrophoresis in the presence of the peptide and 0.1 mM
CaCl2 or 2 mM EGTA. Urea gels contained 13% acrylamide, 4 M urea, 0.375 M Tris-HCl, pH 8.8, and 0.1 mM CaCl2, or 2 mM EGTA and
were run at a constant voltage of 100 V in electrode buffer consisting
of 25 mM Tris-HCl, 192 mM glycine, pH 8.3, and 0.1 mM CaCl2, or 2 mM EGTA. The
SCaM-1 or SCaM-4 isoform and increasing concentrations of Pep A and B
(molar ratio: 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, and 2.5) were incubated
at room temperature for 1 h in 100 mM Tris-HCl, pH
7.2, 4 M urea, and 0.1 mM CaCl2, or
2 mM EGTA. Glycerol (50%) with tracer bromphenol blue was
added before the samples were loaded onto the gel.
Fluorescence Spectroscopy--
The changes in the
microenvironments of the peptide Trp residues upon binding to SCaM were
monitored by fluorescence spectroscopy using a PerkinElmer Life
Sciences LS50 luminescence spectrometer. The excitation and emission
slit widths were 2 nm, and emission spectra scanning was carried out at
10 nm/min with a 1-cm path length cuvette. The Trp residues of Pep A
and B incubated in Ca2+ buffer (50 mM Mops, pH
7.5, 0.1 M KCl, 0.1 mM CaCl2) or in
EGTA buffer (50 mM Mops, pH .5, 0.1 M KCl, 2 mM EGTA) at room temperature for 30 min were excited at a
295 nm excitation wavelength, and the fluorescence emission spectra in
the range 295-560 nm were recorded. An excitation wavelength of 295 nm
was used to decrease Tyr fluorescence in SCaM. SCaM was added to the
same cuvette from a highly concentrated stock solution to maximize the
dilution effects.
Circular Dichroism--
CD spectra were obtained on a Jasco
J-720 spectropolarimeter using a 1-mm cell at 25 °C. The peptide
concentration used for CD measurements was 50 µM, and the
solutions included 10 mM Tris-HCl, pH 7.5, and 50%
2,2,2-trifluoroethanol (TFE) (v/v). Secondary structure contents were
calculated using the Circular Dichroism Deconvolution program (34).
Phosphodiesterase (PDE) Competition Assay--
Cyclic nucleotide
PDE assays were performed using commercially available bovine heart
CaM-deficient PDE (Sigma). The initial 100-µl reaction volume
contained buffer (100 mM imidazole HCl, 2.56 mM
cAMP, 5.13 mM MgSO4, 1.28 mM
CaCl2) and varying concentrations of SCaMs (5-200
nM) in the presence (100 nM of either Pep A or Pep B) or absence of peptides. The reaction was started by the addition
of PDE (0.3 milliunits/µl). The basal level of enzyme activity was
determined in the absence of SCaM, and stimulated activity was
determined in the presence of either SCaM-1 or SCaM-4 and
CaCl2. After an incubation at 37 °C for 30 min, the
reactions were stopped by placing the reaction tubes in a boiling water bath for 5 min and then on ice for 2 min. Following a brief
centrifugation step, 50 µl of alkaline phosphatase (10 units) was
added, and the samples were incubated for 10 min at 37 °C. The
reactions were stopped by adding 500 µl of 10% trichloroacetic acid.
After vortexing, the precipitates were pelleted, and the supernatants (400 µl) were transferred to new tubes. One ml of phosphate reagent (22) was then added, and samples were incubated for 15 min at 37 °C
and assayed for Pi content at OD660. The
dissociation constants (Kd) of SCaM-1 and -4 for Pep
A and B were calculated from the concentration of SCaM (nM)
required to obtain half-maximal PDE activity either in the presence
(100 nM) or absence of the peptides. The following equation
(35) was used to calculate the dissociation constants:
Kd = ([Pt] + K
[CaM])K/([CaM]
K), where
[Pt] represents the total concentration of peptide
added, and [CaM] and K are the concentrations of CaM
required to obtain half-maximal activation of PDE in the presence or
absence of peptides, respectively. The Kd for Pep A
or B binding to SCaM-1 or -4 was calculated using the following values:
[Pt] = 100 nM, K = 9.7 nM (for Pep A) or 10.5 nM (for Pep B)
(calculated from the SCaM-1 or -4 activation curves in the absence of
Pep A or B), [SCaM] = 33.6 nM (for Pep A) or 37.4 nM (for Pep B) (calculated from the SCaM activation curve
in the presence of 100 nM Pep A or B).
 |
RESULTS |
Construction and Characterization of the Random 22-mer Peptide
Phage Display Library--
The 22-mer phage display random peptide
libraries were constructed using a modified pCANTAB vector, as
described in Fig. 2. Random peptides of 22 amino acids in length are
expressed at the N terminus of the M13 protein III bacteriophage.
Initial transformation of the library produced 4.8 × 108 independent clones and subsequent amplification yielded
2.3 × 1011 pfu/ml. To confirm the diversity of
peptide sequences in the library, we randomly picked 80 individual
phage clones and determined nucleotide sequences of random peptide
regions. In Fig. 3A, the distribution of amino acids in the 22-mer random peptide library is
reported as a percentage of the total. All amino acids were uniformly
distributed in this library, taking into account the bias inherent in
the codon usage ratio. The distribution of amino acid types that
appears at each residue position of the sequenced inserts is shown
graphically in Fig. 3B. Acidic (Asp and Glu), basic (Lys,
Arg, and His), polar (Ser, Thr, Cys, Tyr, Asn, and Gln), and nonpolar
amino acids (Gly, Ala, Val, Leu, Ile, Pro, Phe, Trp, and Met) are
relatively proportional to their presence in the genetic code and
generate not only linear sequence diversity but also the biochemical
diversity desired in a library for screening.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 3.
Amino acid distribution in the 22-mer random
peptide library. A, a total of 80 peptide sequences
from the 22-mer random library was obtained and analyzed as described
under "Experimental Procedures." The percentage of each total amino
acid was determined. B, frequency and positional
distribution are listed for the amino acid types in the 22-mer random
peptide library. The amino acids were divided into acidic (Asp and
Glu), basic (Lys, Arg, and His), nonpolar (Gly, Ala, Val, Leu, Ile,
Pro, Phe, Trp, and Met), and polar (Ser, Thr, Cys, Tyr, Asn, and Gln)
species. The frequency of each amino acid type at each residue position
is indicated as follows: acidic, dotted bars; basic,
open bars; nonpolar, hatched bars; and polar,
filled bars.
|
|
Isolation of SCaM-1- and SCaM-4-binding Peptides--
In an effort
to study the binding sequence preferences of the SCaM-1 and SCaM-4
isoforms, we screened a phage display peptide library by biopanning
with purified SCaM-1 and SCaM-4 proteins, respectively (see under
"Experimental Procedures"). Briefly, SCaM-1 or SCaM-4 proteins
immobilized on the surface of plastic Petri dishes were incubated with
phages in the presence of Ca2+. Bound phages were eluted
with EGTA after extensive washing. After three rounds of selection,
isolated phage clones were tested for specific binding to SCaM-1 or
SCaM-4 via an enzyme-linked immunosorbent assay-based assay (see
"Experimental Procedures"). Approximately 90% of the isolates
exhibited strong SCaM-1- or -4-binding activity (data not shown). Each
of the 80 independent phages reacting strongly in the enzyme-linked
immunosorbent assay were selected from the SCaM-1- and SCaM-4
biopanning, and their nucleotide sequences were determined. In Fig.
4, their deduced amino acid sequences are
shown in random peptide regions, which are aligned to reveal consensus
sequences. For convenience, we designated SCaM-1-binding peptide
sequences as the
-series and SCaM-4-binding peptides as the
-series. Despite the considerable sequence diversity observed among
these clones, their careful alignment yields two distinct binding
motifs. Based on the positions of conserved hydrophobic residues,
SCaM-1-binding peptides can be fit into a 1-5-10 motif, possessing a
consensus sequence of ((FILVW)XXX(FILV)) (where X
denotes any amino acid). In contrast, SCaM-4-binding peptides conformed
to a 1-8-14 motif of
((FILVW)XXXXXX(FAILVW)XXXXX(FILVW)). In both
cases, most of these peptide sequences contain one or more basic amino
acid residues, which results in an overall positive net charge for
these peptides.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Deduced amino acid sequences derived from the
phage display library by affinity selection with SCaM-1
(A) or SCaM-4 (B). Phages from a
22-mer random peptide display library were subjected to three rounds of
selection on SCaM-1 or SCaM-4 affinity panning. Each of the 80 independent phages selected for its strong enzyme-linked immunosorbent
assay signal was selected from SCaM-1- or SCaM-4 biopanning. Their
nucleotide sequences were determined, and the deduced amino acids are
compared. Boldface residues indicate the three hydrophobic
amino acids that are grouped into one of two types (the 1-5-10 ((FILVW)XXX(FILV)XXXX(FILVW)) motif represents
the SCaM-1-binding peptides, and the 1-8-14 ((FILVW)XXXXXX(FAILVW)XXXXX(FILVW)) motif
represents the SCaM-4-binding peptides) based on the positions of
conserved hydrophobic residues. The frequency of appearance
(n) and electrostatic charge of each of the isolates is
indicated as shown.
|
|
Identification of SCaM-1- or -4-specific Peptides by Gel
Overlay Assay--
To verify the specificity of SCaM-binding phage
isolation using biopanning, a CaM gel overlay assay was performed (24). First of all, three of the most frequently isolated peptides obtained from each of the SCaM-binding phages (i.e.
1,
2, and
3 for SCaM-1 and
1,
2, and
3 for SCaM-4) were expressed as
GST fusion proteins using the vector pGEX-KG (30). As shown in Fig.
5, these GST fusion proteins exhibited
molecular masses of ~29 kDa by SDS-PAGE, consistent with the
predicted values of ~3 kDa for the SCaM peptide plus ~26 kDa for
the GST protein. In the gel overlay assays, all
peptide fusion
proteins exhibited positive signals with SCaM-1-HRP (Fig.
5A), whereas SCaM-4-HRP resulted in no signal. Conversely,
for the
peptide fusion proteins, only SCaM-4-HRP exhibited positive
binding. Interestingly, CaM binding signals for these fusion proteins
correlated with their frequency of isolation in the biopanning. For
example,
1 and
1, the most frequently isolated sequences for
SCaM-1 and SCaM-4 binding, respectively, produced the strongest signals
among the tested
and
peptides in the gel overlays (Fig. 5,
A and B). In either case, the negative control
(i.e. GST protein alone) exhibited no binding to either of
the SCaM-HRP probes. In addition, no significant signal was detected
when the gel overlay assays were performed in the presence of an
EGTA-containing buffer (data not shown). Thus, these results indicate
that these peptide sequences specifically bind to the corresponding
SCaM-1 or SCaM-4 in a Ca2+-dependent
manner.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 5.
SCaM gel overlay of isolated peptides.
The GST fusion proteins were prepared as described under
"Experimental Procedures." Equal amounts (10 µg) of total
E. coli protein extracts were subjected to SDS-PAGE (11%
gel), and stained by Coomassie Brilliant Blue (left 1st
panels). The protein gels were transferred to nitrocellulose
membranes and probed with anti-GST antibody (Ab) to detect
the expression of GST fusion peptides (2nd panels from
left) and probed further with either SCaM-1-HRP (3rd
panels from left) or SCaM-4-HRP (right
panels). The bound SCaM-1-HRP or SCaM-4-HRP was detected using an
ECL system (Amersham Biosciences). M indicates protein
molecular weight marker, A shows the SCaM-1-favored
peptides, and B shows the SCaM-4-favored peptides.
|
|
Gel Mobility Shift Assays--
The gel overlay assays confirmed
the binding of SCaM to the isolated peptide sequences. However, they
did not provide quantitative information for these interactions. To
examine further the SCaM-binding specificity of the isolated peptide
sequences, the most frequently isolated peptide sequence was selected
from each SCaM-1 or SCaM-4-binding peptide sequence. These are
designated as Pep A (APAHALFHWGVLGSLIRLVFLS) and Pep B
(CNRLLLRSLRYWGYVVLSALRL), respectively. The synthesized peptides were
then tested by gel mobility shift to assess their interactions with the
SCaM isoforms. Complexes formed between the SCaM isoforms and either
Pep A or Pep B were confirmed by gel electrophoresis in the presence of
4 M urea. Urea was used since it dissociates low affinity
and nonspecific complexes, leaving only the higher affinity and higher
specificity complexes behind. As the ratio of peptide to
Ca2+-SCaM increased, we observed a band shift due to the
formation of a complex between the peptide and Ca2+-SCaM
(Fig. 6, A and D).
In the absence of peptide, SCaM migrates as a single band (data not
shown). When the ratio of peptide to SCaM was equal, a mobility shift
was observed for nearly all of the SCaM proteins. At a peptide to SCaM
molar ratio of 1.5, virtually no free SCaM was detected. Taken
together, these observations indicate that the peptides bind to the
Ca2+-bound SCaM isoforms at a 1:1 molar stoichiometry. This
is consistent with the previous observation (36) that most of the well
characterized CaM-binding peptides, including peptides derived from
myosin light chain kinase, constitutive nitric-oxide synthase, and
CaM-dependent protein kinase I form a 1:1 complex with
Ca2+-CaM. No mobility shift was observed when 5 mM EGTA was added to the samples, indicating that the
interactions between the SCaM isoforms and the peptides are
Ca2+-dependent (Fig. 6, B and
E). Interestingly, we could detect neither a SCaM-1-Pep B
nor a SCaM-4-Pep A complex in the mobility shift assay (Fig. 6,
C and F). These results suggest that in the
presence of Ca2+, Pep A and Pep B form a 1:1 complex with
SCaM-1 and SCaM-4, respectively. Additionally, these peptides possess a
certain degree of specificity toward the SCaM isoforms.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
Gel mobility shift assay for peptide-SCaM
isoform complexes. Complex formation between SCaM isoforms and
either Pep A or Pep B was determined in the presence of either 0.1 mM CaCl2 or 2 mM EGTA. Purified
SCaM-1 or SCaM-4 was incubated with increasing amounts of Pep A or B
(Pep A or B versus SCaM-1 or -4 molar ratios are indicated),
and then samples were separated by nondenaturing PAGE in the presence
of 4 M urea. The gels were stained with Coomassie Brilliant
Blue. A indicates SCaM-1 + Pep A + Ca2+;
B indicates SCaM-1 + Pep A + EGTA; C indicates
SCaM-4 + Pep A + Ca2+; D indicates SCaM-4 + Pep
B + Ca2+; E indicates SCaM-4 + Pep B + EGTA; and
F indicates SCaM-1 + Pep B + Ca2+. The
arrows in A and D indicate the
SCaM-1-Pep A or SCaM-4-Pep B complexes, respectively. Free peptide is
not apparent because it had run out of the gels by the time
electrophoresis was stopped.
|
|
Trp Fluorescence Emission Spectra--
The peptide interactions
with SCaM-1 or -4 were also examined by taking advantage of the
intrinsic fluorescence of the Trp residue in the peptide sequences.
Fluorescence spectroscopy is a convenient method for determining the
SCaM-peptide complex. The peptides have excitation and emission
wavelengths of 295 and 295-560 nm, respectively. The maximum emission
of the peptide in the absence of CaM occurred at 353 nm (Fig.
7). Upon addition of SCaM-1 or -4 to the
reaction mixtures containing Pep A or Pep B in the presence of
Ca2+, the maximum fluorescence emission of the synthetic
peptides shifted to shorter wavelengths (i.e. for SCaM-1 it
was from 353 to 333 nm and for SCaM-4 it was from 353 to 335 nm) and
exhibited ~5-fold increase in intensity. This relatively large blue
shift indicates that the Trp residues were in a hydrophobic environment such as the interior of SCaM, which is typical for CaM-binding peptides
(37). The addition of 2 mM EGTA to the same reaction mixture completely reversed the shift in the emission spectrum (Fig.
7). These results revealed that each of the SCaM peptides bind directly
to its corresponding SCaM isoform.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
Trp fluorescence spectra of peptide binding
to SCaM isoforms. Rp fluorescence spectra
were measured in the presence of Ca2+ or EGTA using a
PerkinElmer Life Sciences LS50 luminescence spectrometer. An excitation
wavelength of 295 nm was used to reduce Trp fluorescence from SCaM-1
(A) and SCaM-4 (B). SCaM-1 or -4 (2.5 µM) was added in a solution containing 1.9 µM Pep A or B in the presence of either 0.1 mM Ca2+ or 2 mM EGTA.
|
|
Circular Dichroism Spectra--
To examine the molecular basis of
the binding specificity for the plant CaM isoforms, we characterized
the secondary structures of the model peptides. Because shorter
peptides tend to exist as flexible coils in pure water, we determined
the secondary structures of the model peptides in the presence of 50%
TFE, a compound that stabilizes secondary structures (38). In Fig.
8, the CD spectra for Pep A and Pep B
obtained at 25 °C are presented. As can be seen, the spectra are
very similar to each other. Both contain a minimum at 206-208 nm with
a shoulder at around 222 nm, indicating the dominant presence of
-helices. From the CD spectra, the
-helix contents of Pep A and
Pep B are estimated to be 72 and 76%, respectively. Thus, both Pep A
and Pep B are likely to bind CaM isoforms as helices. In addition, in
their SCaM-1-bound forms, both peptides showed increases in their
-helical content, further supporting this theory (data not
shown).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 8.
CD spectra of Pep A and Pep B. CD
spectra of Pep A ( ) and Pep B (····) were measured in 50%
TFE (v/v). Five consecutive scans (250-200 nm) for each sample were
averaged to generate a spectrum.
|
|
Peptide-dependent Inhibition of CaM-activated PDE
Activity--
Finally, the relative affinities of Pep A and Pep B
for the SCaM isoforms were determined by using a competition assay for PDE, an enzyme that is activated equally by both SCaM-1 and SCaM-4 (22). In Fig. 9, A and
B, the effect of increasing peptide concentrations on PDE
activity is shown for a fixed concentration (120 nM) of SCaM-1 or SCaM-4, a concentration sufficient for the maximal activation of PDE. A gradual decrease in PDE activity was observed with increasing concentrations of the relevant peptides. Half-maximal inhibition of PDE
activation by SCaM-1 and SCaM-4 was obtained at ~120 nM Pep A and ~80 nM Pep B, respectively. Up to a
concentration of 600 nM, Pep A had no effect on the
activation of PDE by SCaM-4 and a concentration of more than 1 µM was required to reach half-maximal inhibition. Pep B,
on the other hand, was a slightly more potent inhibitor of PDE
activation by SCaM-1, inhibiting at concentrations above 400 nM, and although similar to Pep A, half-maximal inhibition was not reached at concentrations below 1 µM. To
determine Kd values for these peptides in the
activation of PDE by SCaMs, the CaM dose-dependent
activation of PDE was determined in the presence (100 nM)
or absence of the peptides (Fig. 9, C and D). The
activation curves shifted to the right in the presence of the peptides,
indicating a competition occurring between PDE and the peptides for the
SCaM isoforms. The Kd values for Pep A and Pep B for
their inhibition of the activation of PDE by SCaM-1 or SCaM-4 was
determined to be 31.0 and 28.5 nM, respectively (Fig. 9,
C and D). These experiments suggest that Pep A
and Pep B have at least a 10-fold specificity for SCaM-1 and SCaM-4,
respectively.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 9.
Effect of Pep A and Pep B on the activation
of PDE by SCaM isoforms. The dose-dependent
inhibitions of PDE activity by Pep A and Pep B are shown. The
inhibitory activities were measured in the presence of Ca2+
and a fixed concentration (120 nM) of SCaM-1 (A)
or SCaM-4 (B) with increasing concentrations of Pep A or Pep
B. PDE activity was measured in the presence of varying concentrations
of SCaM-1 or SCaM-4 and either in the presence or absence of fixed
concentrations (100 nM) of Pep A (C) or Pep B
(D). Results are shown as the means obtained from three
independent assays (n = 3).
|
|
 |
DISCUSSION |
We have shown previously (22, 26-28, 33) that SCaM isoforms
exhibit differences in their abilities to activate target enzymes. Importantly, some CaM isoforms competitively inhibit the activation of
certain enzymes by other CaM isoforms, exhibiting a reciprocal regulation of target enzymes (26, 28). In these in vitro
enzyme assays, the SCaM isoforms often possessed significantly
different affinities for a given enzyme. For example, with the
activation of plant Ca2+-ATPase, SCaM-1 has ~20-fold
higher affinity than SCaM-4 (28). Furthermore, in gel overlay assays of
various plant CaM-binding proteins, these isoforms exhibited different
binding intensities, suggesting that different CaM isoforms might
require distinct primary sequences for optimal target binding (24). In
this investigation, in which we took advantage of a phage-displayed
random peptide library, we identify the peptide sequences that interact
with specific SCaM isoforms. Surprisingly, two distinct families of peptides that specifically bind to SCaM-1 or SCaM-4 isoforms in a
Ca2+-dependent manner were identified in this
study. These peptides fit into a 1-5-10 ((FILVW)XXX(FILV)XXXX(FILVW)) motif for the SCaM-1-binding peptides and a 1-8-14 ((FILVW)XXXXXX(FAILVW)XXXXX(FILVW)) motif for the
SCaM-4-binding peptides. Rhoads and Friedberg (17) originally
identified these motifs as Ca2+-dependent brain
CaM-binding sequences, based upon the positions of conserved
hydrophobic amino acid residues. These hydrophobic residues play an
important role in anchoring peptides to target binding pockets of CaM
via a hydrophobic interaction. It is also noteworthy that these
Ca2+-dependent CaM-binding motifs require basic
residues, which are important in stabilizing the binding interaction by
forming salt bridges. Consistent with this, all of the isolated
peptides in this study were determined to be basic.
It is quite remarkable that plant CaM isoforms exhibit differing
optimal sequence preferences for their target interactions in
vitro. This is most likely due to structural differences between CaM isoforms. For example, SCaM-1 and SCaM-4 are ~22% different in
regard to their primary amino acid sequences. What is the significance of this finding in terms of the function of CaM in plant cells? One
intriguing possibility is that certain CaM isoforms may require specific binding targets thereby leading to unique cellular responses. This is consistent with the idea that these CaM isoforms evolved independently following segregation from a progenitor CaM, as predicted
from phylogenetic analyses of these CaM isoforms (22). However, we
should also point out that these isolated peptides could be the optimal
binding sequences for given CaM isoforms, which are not found in
nature. Indeed, in CaM gel overlay assays using plant cell extracts, we
could hardly find binding proteins specific for the CaM isoforms (24).
In addition, so far none of the enzymes tested in vitro in
our laboratory exhibit specific binding to particular CaM isoforms.
Furthermore, the differences in binding affinity between Pep A and Pep
B to the SCaM isoforms were no greater than 10-fold. Therefore, it is
reasonable to speculate that a large number of CaM-binding proteins
bind to both isoforms, given a certain degree of affinity differences,
and therefore only a few CaM isoform-specific binding proteins may
exist in plants.
We reported previously that SCaM isoforms are different in their
abilities to activate various target enzymes (28, 33). We examined
whether there is a correlation between the differential target binding
preferences for the activation profiles of SCaMs. Interestingly, in the
case of
-CaMKII, which has a 1-5-10 CaM-binding motif, the
1-5-10-favoring SCaM-1 activated this enzyme and at a much lower
concentration than SCaM-4 (~10-fold less, Kact
22 versus 275 nM). Conversely, SCaM-4 was
>4-fold better than SCaM-1 in the activation of nitric-oxide synthase,
a 1-8-14-type enzyme (28). These positive correlations further support
the biological relevance of our findings.
Previously, two other groups (39, 40) reported isolating CaM-binding
sequences using similar strategies. Dedman et al. (39)
pioneered this type of work using a random 15-mer library, shorter than
the typical CaM-binding domains, to screen for CaM-binding peptides.
Among the 28 isolated peptides, Trp was always present and often (11 peptides) present in the first variable position of the random peptide
inserts. Additionally, 17 of the peptides contained Trp-Pro sequences.
Nevalainen et al. (40) used a random 8-mer peptide library
and similarly found the Trp residue and the Trp-Pro combination in the
isolated CaM-binding peptides. Because they used a random peptide
library consisting of lengths shorter than those of the naturally
occurring CaM-binding sequences, the peptides binding to CaM might be
the flanking amino acid sequences present in the vector, potentially
posing a significant bias. In this regard, the 22-mer random peptide
library used in this study has merit over those peptides possessing
pre-determined constraints, and it is also long enough to span the
length of the hydrophobic binding surface of CaM. These advantages
might prove useful in the isolation of CaM-binding sequences that are more like naturally occurring CaM-binding peptides. The majority of the
30 plus CaM-binding domains identified thus far consists of stretches
of 16-35 amino acid residues. Of the 33 peptides isolated in this
study, Trp residues are found present at random positions (6 of them
are actually devoid of the Trp residue), and only two of the peptides
(i.e.
12 and
16) contain the Trp-Pro configuration. In
addition, the 1-5-10 and 1-8-14 consensus motifs found in this study
were originally identified in natural CaM-binding sequences, further
arguing that the peptides isolated in this study resemble naturally
occurring sequences.
What is the importance of our findings in regard to the structural
perspective of the CaM-target peptide interaction? To address this, we
built model structures of SCaM-1 bound to either M13 (of the 1-8-14 motif) or to the CaMKII CaM-binding sequence (of the 1-5-10 motif). The
same models were prepared for SCaM-4. We then looked for any steric
hindrance between SCaM and each of the peptides, hoping to discover any
structural reason that would support our observation of the
differential binding specificity. In short, we could not find any
obvious reason that would clearly explain the basis of the binding
discrimination of the SCaMs. However, we should note that this kind of
modeling study assumes that both of the SCaM isoforms adopt the same
conformation as that of target-bound mammalian CaM. Thus, the lack of a
positive answer resulting from the model studies suggests two
possibilities. First, SCaM isoforms may contain subtle differences in
their side chain conformations of the residues directly interacting
with target peptides despite the fact that their overall structures are
similar to that of mammalian CaM. This would be similar to the
structure of yeast CaM which is only 60% identical to mammalian CaM at
the amino acid level (41). Indeed, we noticed that many Met residues in
the SCaM isoforms were substituted for bulky hydrophobic amino acids
such as Ile, Leu, and Val, which are involved in stabilizing the
CaM-target peptide complex, by forming hydrophobic interactions and are
also important for conferring flexibility to accommodate and recognize
a wide range of targets (12). Alternatively, the overall structure of
the SCaM isoforms might be different from that of mammalian CaM and may
use different mechanisms for target binding than that of mammalian CaM.
Therefore, only by high resolution three-dimensional structure
determination of the complex with different peptides can the exact
mechanism underlying the differential binding specificity of the SCaMs
be determined.
The potential merits of this study are severalfold. First, the isolated
CaM-binding sequences may serve as good references for searching for
CaM-binding proteins in data bases or for mapping the CaM-binding
domains of certain proteins. Second, these peptides may serve as useful
tools for studying CaM isoform-specific functions in plant cells. For
example, in regard to each other, Pep A and Pep B exhibit at least a
10-fold higher specificity for SCaM-1 and SCaM-4, respectively, in both
gel overlay and PDE inhibition assays. Another advantage of these
techniques is that one can study the function of CaM in different
subcellular compartments by tagging the inhibitor peptide to various
subcellular targeting sequences. For example, its nuclear function can
be studied by fusing it to a nuclear localization signal (6). Currently
these studies are underway in our laboratory.
 |
ACKNOWLEDGEMENTS |
We are indebted to Dr. Mitsuhiko Ikura and
Kyoko L. Yap (Department of Medical Biophysics, University of Toronto)
for help in the modeling studies.
 |
FOOTNOTES |
*
This work was supported by Grant 2000-2-20900-001-1 from
KOSEF, the National Research Laboratory (2000), and BK21 Program.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
**
To whom correspondence should be addressed: Division of Applied
Life Science, Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Chinju 660-701, Korea. Tel.:
82-55-751-5957; Fax: 82-55-759-9363; E-mail:
mjcho@nongae.gsnu.ac.kr.
Published, JBC Papers in Press, March 18, 2002, DOI 10.1074/jbc.M110803200
2
Munich Information Center for Protein
Sequences, mips.gsf.de/ proj/thal/.
 |
ABBREVIATIONS |
The abbreviations used are:
CaM, calmodulin;
BSA, bovine serum albumin;
HRP, horseradish peroxidase;
gpIII, minor
coat protein;
PDE, 3',5'-cyclic nucleotide phosphodiesterase;
SCaM, soybean calmodulin;
TBS, Tris-buffered saline;
TFE, 2,2,2-trifluoroethanol;
GST, glutathione S-transferase;
Mops, 4-morpholinepropanesulfonic acid.
 |
REFERENCES |
| 1.
|
Lu, K. P.,
and Means, A. R.
(1993)
Endocr. Rev.
14,
40-58[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Crivici, A.,
and Ikura, M.
(1995)
Annu. Rev. Biophys. Biomol. Struct.
24,
85-116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Bush, D. S.
(1995)
Annu. Rev. Plant Physiol. Plant Mol. Biol.
46,
95-122[CrossRef]
|
| 4.
|
Snedden, W. A.,
and Fromm, H.
(1998)
Trends Plant Sci.
3,
299-304
|
| 5.
|
Zielinski, R. E.
(1998)
Annu. Rev. Plant Physiol. Plant Mol. Biol.
49,
697-725[CrossRef]
|
| 6.
|
Wang, J.,
Campos, B.,
Jamieson, G. A.,
Kaetzel, M. A.,
and Dedman, J. R.
(1995)
J. Biol. Chem.
270,
30245-30248[Abstract/Free Full Text]
|
| 7.
|
Lee, A.,
Wong, S. T.,
Gallagher, D., Li, B.,
Storm, D. R.,
Scheuer, T.,
and Catterall, W. A.
(1999)
Nature
399,
155-159[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Liao, B.,
Paschal, B. M.,
and Luby-phelps, K.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6217-6222[Abstract/Free Full Text]
|
| 9.
|
Zuhlke, R. D.,
Pitt, G. S.,
Deisseroth, K.,
Tsien, R. W.,
and Reuter, M.
(1999)
Nature
399,
159-162[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Babu, Y. S.,
Bugg, C. E.,
and Cook, W. J.
(1988)
J. Mol. Biol.
204,
191-204[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
O'Neil, K. T.,
and DeGrado, W. F.
(1990)
Trends Biochem. Sci.
15,
59-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Ikura, M.,
Clore, G. M.,
Gronenborn, A. M.,
Zhu, G.,
Klee, C. B.,
and Bax, A.
(1992)
Science
256,
632-638[Abstract/Free Full Text]
|
| 13.
|
Meador, W. E.,
Means, A. R.,
and Quiocho, F. A.
(1992)
Science
257,
1251-1255[Abstract/Free Full Text]
|
| 14.
|
Meador, W. E.,
Means, A. R.,
and Quiocho, F. A.
(1993)
Science
262,
1718-1721[Abstract/Free Full Text]
|
| 15.
|
Afsha, M.,
Caves, L. S. D.,
Guimard, L.,
Hubbard, R. E.,
Calas, B.,
Grassy, G.,
and Haiech, J.
(1994)
J. Mol. Biol.
244,
554-571[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Yuan, T.,
Vogel, H. J.,
Sutherland, C.,
and Walsh, M. P.
(1998)
FEBS Lett.
431,
210-214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Rhoads, A. R.,
and Friedberg, F.
(1997)
FASEB J.
11,
331-340[Abstract]
|
| 18.
|
Yap, K. L.,
Kim, J.,
Truong, K.,
Sherman, M.,
Yuan, T.,
and Ikura, M.
(2000)
J. Struct. Funct. Genomics
1,
8-14[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Yang, T.,
Segal, G.,
Abbo, S.,
Fedman, M.,
and Fromm, H.
(1996)
Mol. Gen. Genet.
252,
684-694[Medline]
[Order article via Infotrieve]
|
| 20.
|
Poovaiah, B. W.,
Takezawa, D., An, G.,
and Han, T. I.
(1996)
J. Plant Physiol.
149,
553-558[Medline]
[Order article via Infotrieve]
|
| 21.
|
Gawienowski, M. C.,
Szymanski, D.,
Perera, I. Y.,
and Zielinski, R. E.
(1993)
Plant Mol. Biol.
22,
215-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Lee, S. H.,
Kim, J. C.,
Lee, M. S.,
Heo, W. D.,
Seo, H. Y.,
Yoon, H. W.,
Hong, J. C.,
Lee, S. Y.,
Bahk, J. D.,
Hwang, I.,
and Cho, M. J.
(1995)
J. Biol. Chem.
270,
21806-21812[Abstract/Free Full Text]
|
| 23.
|
Falke, J. J.,
Drake, S. K.,
Hazard, A. L.,
and Peersen, D. B.
(1994)
Q. Rev. Biophys.
27,
219-290[Medline]
[Order article via Infotrieve]
|
| 24.
|
Lee, S. H.,
Kim, M. C.,
Heo, W. D.,
Kim, J. C.,
Chung, W. S.,
Park, C. Y.,
Park, H. C.,
Cheong, Y. H.,
Kim, C. Y.,
Lee, S.,
Lee, K. J.,
Bahk, J. D.,
Lee, S. Y.,
and Cho, M. J.
(1999)
Biochim. Biophys. Acta
1433,
56-67[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Heo, W. D.,
Lee, S. H.,
Kim, M. C.,
Kim, J. C.,
Chung, W. S.,
Chun, H. J.,
Lee, K. J.,
Park, C. Y.,
Park, H. C.,
Choi, J. Y.,
and Cho, M. J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
766-771[Abstract/Free Full Text]
|
| 26.
|
Cho, M. J.,
Vaghy, P. L.,
Kondo, R.,
Lee, S. H.,
Davis, J. P.,
Rehl, R.,
Heo, W. D.,
and Johnson, J. D.
(1998)
Biochemistry
37,
15593-15597[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Kondo, R.,
Tikunova, S. B.,
Cho, M. J.,
and Johnson, J. D.
(1999)
J. Biol. Chem.
274,
36213-36218[Abstract/Free Full Text]
|
| 28.
|
Lee, S. H.,
Johnson, J. D.,
Walsh, M. P.,
Van Lierop, J. E.,
Sutherland, C., Xu, A.,
Snedden, W. A.,
Kosh-Kosicka, D.,
Fromm, H.,
Narayanan, N.,
and Cho, M. J.
(2000)
Biochem. J.
350,
299-306
|
| 29.
|
Chung, W. S.,
Lee, S. H.,
Kim, J. C.,
Heo, W. D.,
Kim, M. C.,
Park, C. Y.,
Park, H. C.,
Lim, C. O.,
Kim, W. B.,
Harper, J. F.,
and Cho, M. J.
(2000)
Plant Cell
12,
1393-1407[Abstract/Free Full Text]
|
| 30.
|
Pierce, H. H.,
Schachat, F.,
Brandt, P. W.,
Lombardo, C. R.,
and Kay, B. K.
(1998)
J. Biol. Chem.
273,
23448-23453[Abstract/Free Full Text]
|
| 31.
|
Guan, K. L.,
and Dixon, J. E.
(1991)
Anal. Biochem.
192,
262-267[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning, A Laboratory Manual
, 2nd Ed.
, pp. 5.3-6.59, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 33.
|
Lee, S. H.,
Seo, H. Y.,
Kim, J. C.,
Heo, W. D.,
Chung, W. S.,
Lee, K. J.,
Kim, M. C.,
Cheong, Y. H.,
Choi, J. Y.,
Lim, C. O.,
and Cho, M. J.
(1997)
J. Biol. Chem.
272,
9252-9259[Abstract/Free Full Text]
|
| 34.
|
Bohm, G.,
Muhr, R.,
and Jaenicke, R.
(1992)
Protein Eng.
5,
191-195[Abstract/Free Full Text]
|
| 35.
|
Erickson-Vittanen, S.,
and Degrado, W. F.
(1987)
Methods Enzymol.
139,
455-458[Medline]
[Order article via Infotrieve]
|
| 36.
|
Vogel, H. J.
(1994)
Biochem. Cell Biol.
72,
357-376[Medline]
[Order article via Infotrieve]
|
| 37.
|
Yuan, T.,
Weljie, A. M.,
and Vogel, H. J.
(1998)
Biochemistry
37,
3187-3195[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Keller, D.,
Clausen, R.,
Josefsen, K.,
and Led, J. J.
(2001)
Biochemistry
40,
10732-10740[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Dedman, J. R.,
Kaetzel, M. A.,
Chan, H. C.,
Nelson, D. J.,
and Jamieson, G. A.
(1993)
J. Biol. Chem.
268,
23025-23030[Abstract/Free Full Text]
|
| 40.
|
Nevalainen, L. T.,
Aoyama, T.,
Ikura, M.,
Crivici, A.,
Yan, H.,
Chua, N. H.,
and Nairn, A. C.
(1997)
Biochem. J.
321,
107-115
|
| 41.
|
Ishida, H.,
Takahashi, K.,
Nakashima, K.,
Kumaki, Y.,
Nakata, M.,
Hikichi, K.,
and Yazawa, M.
(2000)
Biochemistry
39,
13660-13668[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore